Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,211 | -888 | -122 | -1,296 | -985 |
| Depreciation Amortization | 1,835 | 1,232 | 658 | 2,284 | 1,718 |
| Income taxes - deferred | -15 | -15 | -15 | 25 | 32 |
| Accounts receivable | 95 | 654 | -239 | -705 | 46 |
| Accounts payable and accrued liabilities | -78 | 36 | -239 | -89 | -219 |
| Other Working Capital | 340 | 1,354 | 254 | -1,096 | -709 |
| Other Operating Activity | 194 | -547 | 559 | 1,109 | 398 |
| Operating Cash Flow | $1,159 | $1,827 | $858 | $234 | $280 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 461 | 461 | 1,965 | -2,453 | -7,147 |
| PPE Investments | -3,787 | -2,314 | -1,252 | -941 | -450 |
| Net Acquisitions | N/A | N/A | N/A | -9 | -9 |
| Investing Cash Flow | $-3,326 | $-1,853 | $714 | $-3,403 | $-7,606 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,038 | 10,038 | 8,600 | N/A | N/A |
| Common Stock Issued | 0 | 0 | 0 | 8,303 | 8,303 |
| Other Financing Activity | -8,844 | -8,701 | -8,559 | -1,361 | -1,144 |
| Financing Cash Flow | $1,194 | $1,337 | $41 | $6,942 | $7,159 |
| Beginning Cash Position | 6,293 | 6,293 | 6,293 | 2,521 | 2,521 |
| End Cash Position | 5,320 | 7,604 | 7,905 | 6,293 | 2,355 |
| Net Cash Flow | $-973 | $1,311 | $1,612 | $3,772 | $-167 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,159 | 1,827 | 858 | 234 | 280 |
| Capital Expenditure | -3,788 | -2,315 | -1,252 | -1,391 | -700 |
| Free Cash Flow | -2,629 | -488 | -395 | -1,158 | -420 |